Startup Funding: July 2022 semiengineering.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from semiengineering.com Daily Mail and Mail on Sunday newspapers.
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
SpyBiotech raises $32.5M in Series A funding and appoints Lutz B. Giebel as Chairman to support .
SpyBiotechFebruary 10, 2021 GMT
SpyBiotech has raised $32.5M from leading investors to advance development of its novel “plug and display” vaccine platform technology
Braavos Investment Advisers led the round, joined by new investor Oxford Investment Consultants; founding investors Oxford Sciences Innovation and GV also participated
Lutz B. Giebel joins as Chairman, strengthening governance as company expands clinical development and builds operational resource
ADVERTISEMENT
OXFORD, United Kingdom, Feb. 10, 2021 (GLOBE NEWSWIRE) SpyBiotech, a British biotechnology company with a novel vaccine platform technology targeting infectious diseases, cancer and chronic diseases, today announces it has raised $32.5 million in Series A equity financing and appointed Lutz B. Giebel as Chairma
(1)
SpyBiotech has raised $32.5M from leading investors to advance development of its novel plug and display vaccine platform technology
Braavos Investment Advisers led the round, joined by new investor Oxford Investment Consultants; founding investors Oxford Sciences Innovation and GV also participated
Lutz B. Giebel joins as Chairman, strengthening governance as company expands clinical development and builds operational resource
OXFORD, United Kingdom, Feb. 10, 2021 (GLOBE NEWSWIRE) SpyBiotech, a British biotechnology company with a novel vaccine platform technology targeting infectious diseases, cancer and chronic diseases, today announces it has raised $32.5 million in Series A equity financing and appointed Lutz B. Giebel as Chairman.